News
PERSIMUNE Immunologic Colloquium 21 June 2017

The next Immunologic Colloquium will take place 21 June, 15.30-17.30
Department of Infectious Diseases 8632, Library room 3rd floor

Please find agenda here

 
Jens Lundgren receives the 2017 Hagedorn Prize
Jens Lundgren receives the 2017 Hagedorn Prize from Novo Nordisk Fonden for his pioneering and internationally recognized research on treatment for people living with HIV.

Press release

Novo Nordisk Fonden website (English)  
New PERSIMUNE publication

Read the latest PERSIMUNE publication
Sustainable HIV treatment in Africa through viral-load-informed differentiated care. L Vojnov et al.

 
Statement by the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents Regarding Results
With the availability of the START and TEMPRANO trial results, the Panel’s overall recommendation remains the same: ART is recommended for all HIV-infected patients regardless of pre-treatment CD4 count. However, the strength of the recommendation will be changed to AIa (strong recommendation based on data from randomized controlled trials) for all patients. STATEMENT 
Read the latest news about the START Study results

NIH

Reuters health

IAS2015

DR TV Avisen

EurekAlert

CBC news

Medical Daily

ScienceBlog

Latest News Link

Read all press coverage of the START Study results here

 
Article on START Study results in New England Journal of Medicine

Read the article on the groundbreaking reults of the START Study, on the benefits of early antiretroviral treatment. Now available online

 
Live streaming from IAS2015 press conference on START study results

Follow the live streaming from IAS2015 press conference for the presentation of the groundbreaking results from the START study

 

 
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention 19-22 July 2015

Presentations

The START study: Design, conduct and main results

Presented by Jens Lundgren, Rigshospitalet, University of Copenhagen, Denmark

Monday 20th July 11-12.30 Ballroom A, Session title: The Strategic Timing of Antiretroviral Treatment (START) Study: Results and their Implications. 
PERSIMUNE Newsletter

The latest PERSIMUNE Newsletter is online. Read more about news and developments here

 
BREAKING NEWS: Results of the START study
START, one of the largest ongoing HIV studies, has announced early results regarding the long-debated question of when to start HIV-infected individuals on treatment. 

Read the press release from the NIH here. 

Have questions about the study results and what they mean for HIV patients? Find answers on the NIH Q & A page. 

Go to CHIP's START news page or click on the links below to read what other news sources around the world are saying about the groundbreaking results of the START study: 

UNAIDS

The New York Times

BBC news

ScienceMag.org

Groundup.org

ibase.info 
New Publication of interest

Article on how Amanda Mocroft and colleagues provide a HIV-specific risk score to balance the potential benefits and harms of nephrotoxic ART, based on data from the DAD study. Addressing the need for personalized decision making in the clinic. Read the article

 
Informed Consent form now available in several languages

The PERSIMUNE Informed Consent Form is now available in 10 languages:

Danish, English, Arabic, Farsi, Greenlandic, Faroese, Bosnian, Urdu, Somali and Turkish

 
Copenhagen Summer University

Copenhagen Summer University

A 5 day course in Personalised Medicine - the future treatment paradigm 17th-21st August. Dealine for registration is 28th of May.

Read more about the course and sign up here

Copenhagen Summer University for working professionals

English

Danish

 

 
PERSIMUNE Newsletter

Read the latest Newsletter for updates on PERSIMUNE
Newsletter 23 April

 
First PERSIMUNE article

The first PERSIMUNE article is on the cover of PLoS Medicine "Development and Validation of a Risk Score for Chronic Kidney Disease in HIV infection Using Prospective Cohort Data from the D:A:D study"

An open access tool to calculate individual patient risk of chronic kidney disease was released in conjunction with the publication of the article

 

 

 
Approval from National Danish Data Authorities

PERSIMUNE has now received approval from the National Danish Data Authorities to commence the recruitment of patients prospectively into the PM platform incl enrolment into the PM biobank. Find Informed Consent Form and Guidance on how to start enrolment here

 
PERSIMUNE Project Proposal

The PERSIMUNE Project Proposal Form is now available on the website 

 
PERSIMUNE Newsletter

Newsletter 24 February

 
Social Media guide

PERSIMUNE communicates through social media to increase awareness about the new research platform and to share and disseminate findings, events and more. We encourage feedback, discussion and knowledge sharing via social media. Read more on why and how here Social Media guide.pdf

 
PERSIMUNE Scientific retreat

Agenda for PERSIMUNE Scientific retreat 3rd and 4th February.

PERSIMUNE workshop and opening 3rd and 4th feb 2015.pdf 
Programme for the official opening of PERSIMUNE 4th February 2.30 pm

Programme for official opening of PERSIMUNE 

Programme Invitation_2015JAN27.pdf

 
OFFICIAL OPENING OF THE DANISH NATIONAL RESEARCH FOUNDATION CENTRE OF EXCELLENCE PERSIMUNE

The official opening ceremony of PERSIMUNE will take place on 4th February 2015 at 14:30, Øster Allé 56, 5th floor. All are welcome! Kindly reply to: pa-lundgren.rigshospitalet@regionh.dk 
For more information please click here

 
Login